BIIB

Biogen
D

BIIB

Arincen57/100B

Biogen free cash flow 1989–2026

Biogen's free cash flow in Q3 FY2026, the three months to 30 September 2026, was 600.40M USD, down 51.0% on the same quarter a year before. Biogen's free cash flow in fiscal year 2025 was 2.05B USD, down 18.5% on the year before.

Last updated 9 Nov 2026 · Next report 5 Feb 2027

Free cash flow

Free cash flow · -4.0% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 2026———2.25B——
FY202531 Dec 20252.05B-18.48%20.73%2.20B-153.80M13.98
FY202431 Dec 20242.52B+103.57%26.00%2.88B-359.80M17.24
FY202331 Dec 20231.24B+8.02%12.56%1.55B-311.40M8.49
FY202231 Dec 20221.14B-66.17%11.25%1.38B-240.30M7.84
FY202131 Dec 20213.38B-11.12%30.79%3.64B-258.10M22.61
FY202031 Dec 20203.81B-42.03%28.30%4.23B-424.80M23.59
FY201931 Dec 20196.56B+21.17%45.65%7.08B-514.50M35.03
FY201831 Dec 20185.42B+47.06%40.27%6.19B-770.60M26.39
FY201731 Dec 20173.68B-5.70%30.01%4.55B-867.40M17.29
FY201631 Dec 20163.91B+27.11%34.12%4.52B-616.10M17.85
FY201531 Dec 20153.07B+15.78%28.55%3.72B-643.00M13.29
FY201431 Dec 20142.65B—27.35%2.94B-287.80M11.19
FY201331 Dec 2013-1.16B-171.61%-16.79%2.35B-3.51B-4.88
FY201231 Dec 20121.63B+10.15%29.47%1.88B-254.55M6.78
FY201131 Dec 20111.48B+1.65%29.23%1.73B-252.18M6.02
FY201031 Dec 20101.45B+59.65%30.78%1.62B-173.06M5.70
FY200931 Dec 2009909.25M-29.44%20.77%1.07B-165.65M3.14
FY200831 Dec 20081.29B+74.95%31.45%1.56B-275.95M4.37
FY200731 Dec 2007736.53M+14.55%23.22%1.02B-284.11M2.30
FY200631 Dec 2006642.96M+12.58%23.96%841.27M-198.31M1.86
FY200531 Dec 2005571.13M+59.43%33.33%889.50M-318.38M1.65
FY200431 Dec 2004358.22M—22.45%727.99M-369.76M1.04
FY200331 Dec 2003-82.04M-181.08%-44.07%219.21M-301.25M-0.25
FY200231 Dec 2002101.17M-16.26%25.03%267.08M-165.90M0.25
FY200131 Dec 2001120.82M-27.57%11.59%316.36M-195.53M0.30
FY200031 Dec 2000166.82M-10.29%18.02%365.94M-199.12M0.36
FY199931 Dec 1999185.96M+38.53%23.41%272.29M-86.33M0.39
FY199831 Dec 1998134.23M+116.22%24.07%167.85M-33.61M0.14
FY199731 Dec 199762.08M—14.30%97.63M-35.55M0.07
FY199631 Dec 1996-19.10M—-6.89%46.54M-65.64M-0.02
FY199531 Dec 1995-40.86M—-26.94%9.45M-50.31M-0.06
FY199431 Dec 1994-8.78M-123.87%-5.62%34.89M-43.67M-0.01
FY199331 Dec 199336.80M+9.20%26.98%47.60M-10.80M0.05
FY199231 Dec 199233.70M—27.24%43.10M-9.40M0.04
FY199131 Dec 1991-2.50M—-4.07%5.90M-8.40M-0.00
FY199031 Dec 1990-400.00K—-0.80%10.70M-11.10M-0.00
FY198931 Dec 1989-10.60M—-37.19%-7.50M-3.10M-0.03

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about Biogen's free cash flow

Source: Financial Modeling Prep